Carson Wealth (CWM LLC)
DNTH icon

Carson Wealth (CWM LLC)’s Dianthus Therapeutics DNTH Stock Holding History

Carson Wealth (CWM LLC)’s Portfolio DNTH Stock Details DNTH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$11.1K Buy
132
+70
+113% +$4.05K ﹤0.01% 4731
2025
Q4 		$3K Buy
62
+1
+2% +$39 ﹤0.01% 4961
2025
Q3 		$2K Buy
61
+46
+307% +$1.18K ﹤0.01% 4990
2025
Q2 		$0 Sell
15
-2
-12% -$38 ﹤0.01% 5151
2025
Q1 		$0 Buy
17
+8
+89% +$176 ﹤0.01% 5084
2024
Q4 		$0 Buy
9
+4
+80% +$103 ﹤0.01% 4956
2024
Q3 		$0 Buy
+5
New +$139 ﹤0.01% 4889

Other funds holding DNTH

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
FFM
Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Carson Wealth (CWM LLC)'s DNTH Position: Q1 2026 in Review

Carson Wealth (CWM LLC) increased its Dianthus Therapeutics (DNTH) stake by 113% in Q1 2026, buying an estimated $4.05K and bringing the position to 132 shares worth $11.1K. The position accounts for ﹤0.01% of the portfolio, ranked #4731.

Carson Wealth (CWM LLC) first reported a position in DNTH in Q3 2024 and has held it in 7 quarters since. 241 funds tracked by Wall St. Rank hold DNTH as of Q1 2026.

  • Carson Wealth (CWM LLC) held 132 shares of Dianthus Therapeutics worth $11.1K as of Q1 2026.
  • Carson Wealth (CWM LLC) bought 70 Dianthus Therapeutics shares in Q1 2026, an estimated $4.05K.
  • Dianthus Therapeutics made up ﹤0.01% of Carson Wealth (CWM LLC)'s portfolio in Q1 2026, its #4731 holding.
  • Carson Wealth (CWM LLC) first reported a position in Dianthus Therapeutics in Q3 2024 and has held it in 7 quarters since.
  • 241 funds tracked by Wall St. Rank held Dianthus Therapeutics as of Q1 2026.

Based on Carson Wealth (CWM LLC)'s 13F filing for Q1 2026, filed 14 May 2026.